Doctor profile · Federal record
Dr. PARVESH BANSAL, M.D.
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · Sleep Medicine (Internal Medicine) Physician · MELBOURNE, FL
- NPI 1548293442
- Accepts Medicare
- 46 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1400 PINE ST, SUITE A
MELBOURNE, FL 329013170
(321) 676-6000
fax (321) 676-7000
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- March 7, 2023
- Year of graduation
- 1980 — 46 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (2)
- Florida #ME50550 · Florida #ME 50550
- Medicaid
- FL #046576300
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1548293442. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,707
Distinct HCPCS
10
Medicare allowed
$360,102
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 1,150 | 545 | $176 | |
96160 |
Administration and interpretation of patient-focused health risk assessment | 1,027 | 496 | $3 | |
94729 |
Test to examine how well the lungs exchange gases | 398 | 398 | $54 | |
94726 |
Test to determine lung volumes using sensors | 388 | 388 | $52 | |
94618 |
Test for exercise-induced lung stress | 361 | 358 | $33 | |
94010 |
Test to measure expiratory airflow and volume | 351 | 351 | $26 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 333 | 207 | $32 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 255 | 188 | $126 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 127 | 127 | $218 | |
95810 |
Sleep study in sleep lab (6 years or older) | 62 | 61 | $117 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 175. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$1,227
Transactions
49
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $498.71 | |
| GlaxoSmithKline, LLC. | 15 | $252.90 | |
| Insmed, Inc. | 3 | $64.47 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62.30 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54.65 | |
| Harmony Biosciences Llc | 1 | $49.47 | |
| Avadel CNS Pharmaceuticals, LLC | 2 | $48.17 | |
| HARMONY BIOSCIENCES LLC | 1 | $40.30 | |
| JAZZ PHARMACEUTICALS INC. | 2 | $39.83 | |
| Philips North America LLC | 1 | $34.63 | |
| Pulmonx Corporation | 1 | $32.26 | |
| Mylan Specialty L.P. | 1 | $27.57 | |
| Novo Nordisk Inc | 1 | $22.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,119
Patients
377
Total drug cost
$454,151
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 271 | 98 | $6,707 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 200 | 51 | $185,662 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 121 | 53 | $3,746 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 64 | 22 | $37,366 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 62 | 12 | $52,293 |
| Arnuity Ellipta (Fluticasone Furoate) | Brand | 57 | 16 | $17,128 |
| Prednisone | Generic | 54 | 38 | $317 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 50 | 17 | $57,986 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 46 | 14 | $39,718 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 41 | 15 | $32,453 |